Attending Physician Statement- Cancer or Carcinoma in-situ

Similar documents
Attending Physician Statement- Aplastic Anaemia

Attending Physician Statement- Chronic liver disease, End stage liver failure, Liver cirrhosis or Hepatectomy

Attending Physician Statement- Open Heart Surgery

Attending Physician Statement- Benign Brain Tumour or Subdural Haematoma

Attending Physician Statement- Severe Myasthenia Gravis

Attending Physician Statement - Severe asthma

Attending Physician Statement Deafness (Loss of hearing)

Attending Physician Statement- HIV due to blood transfusion

Attending Physician Statement- Heart Attack

Attending Physician Statement- Coronary Artery Disease / Coronary Artery Surgery

Attending Physician Statement- Stroke

Attending Physician Statement- Special Conditions

ATTENDING PHYSICIAN'S STATEMENT KIDNEY FAILURE / SURGICAL REMOVAL OF ONE KIDNEY OR CHRONIC KIDNEY DISEASE

ATTENDING PHYSICIAN'S STATEMENT FULMINANT VIRAL HEPATITIS / HEPATITIS WITH CIRRHOSIS

ATTENDING PHYSICIAN'S STATEMENT END STAGE LIVER FAILURE / LIVER SURGERY / LIVER CIRRHOSIS

ATTENDING PHYSICIAN'S STATEMENT MULTIPLE SCLEROSIS

ATTENDING PHYSICIAN'S STATEMENT ENCEPHALITIS

ATTENDING PHYSICIAN'S STATEMENT BACTERIAL MENINGITIS

Enhancement Date. Summary. For policyholders. aia.com.au. Sub heading

ATTENDING PHYSICIAN'S STATEMENT STROKE / BRAIN ANEURYSM SURGERY OR CEREBRAL SHUNT INSERTION / CAROTID ARTERY SURGERY

ATTENDING PHYSICIAN'S STATEMENT CORONARY ARTERY BY-PASS SURGERY or OTHER SERIOUS CORONARY ARTERY DISEASE

ATTENDING PHYSICIAN'S STATEMENT HIV DUE TO BLOOD TRANSFUSION, ASSAULT, ORGAN TRANSPLANT AND OCCUPATIONALLY ACQUIRED HIV

ATTENDING PHYSICIAN'S STATEMENT BENIGN BRAIN TUMOUR / SURGICAL REMOVAL OF PITUITARY TUMOUR OR SURGERY FOR SUBDURAL HAEMATOMA

ATTENDING PHYSICIAN'S STATEMENT PULMONARY HYPERTENSION

ATTENDING PHYSICIAN'S STATEMENT MAJOR ORGAN / BONE MARROW TRANSPLANTATION

ATTENDING PHYSICIAN'S STATEMENT END STAGE LUNG DISEASE / SURGICAL REMOVAL OF LUNG / SEVERE ASTHMA

ATTENDING PHYSICIAN'S STATEMENT HEART ATTACK / CARDIOMYOPATHY / PERICARDIAL DISEASE / CARDIAC ARRYTHMIA

Critical Illness Claim - Doctor s Statement Blindness (Loss of Sight) / Optic Nerve Atrophy with Low Vision

ATTENDING PHYSICIAN'S STATEMENT APALLIC SYNDROME

Asteron Lifeguard Changes in Detail

Critical Illness Claim Doctor s Statement Motor Neurone Disease

Aviva Group Protection Our guide to cancer

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology

Asteron Lifeguard Changes in Detail

Comprehensive Cancer Cover

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

Futura. Cancer cover guide

Macmillan Publications

ATTENDING PHYSICIAN'S STATEMENT MAJOR HEAD TRAUMA / FACIAL RECONSTRUCTIVE SURGERY / CERVICAL SPINAL CORD INJURY

Table of contents. Page 2 of 40

Critical Illness Claim - Doctor s Statement Deafness (Loss of Hearing) / Cavernous Sinus Thrombosis Surgery or Cochlear Implant Surgery

Comprehensive cancer cover

Comprehensive cancer cover

Clinical Trial Results Database Page 1

Acute: Symptoms that start and worsen quickly but do not last over a long period of time.

Dread Disease Insurance towards local experience

Cancer: recent advances and implications for underwriting

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.

FORM ID. Patient's Personal Details. SECTION A : Medical Record of the Patient. Name. Policy Number. NRIC/Old IC/Passport/Birth Cert/Others

Ines Buccimazza 16 TH UP CONTROVERSIES AND PROBLEMS IN SURGERY SYMPOSIUM

WHAT DOES THE PATHOLOGY REPORT MEAN?

Do you need extra cover for very early stage cancer?

Our office is located at 2030 Drew Street, Clearwater FL, We are on Drew Street, in between N.E Old Coachman Road and Hercules Avenue.

Glossary of Terms Primary Urethral Cancer

Guideline for the Management of Vulval Cancer

MEDICAL DEFINITIONS REFERENCE GUIDES

Melanoma Quality Reporting

BreastScreen Aotearoa Annual Report 2015

Interactive Staging Bee

Frequently Asked Questions

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

Top Tier. Medical Breast Specialist, P.C.

Common Questions about Cancer

Trends in Cancer Survival in NSW 1980 to 1996

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Informed Consent. Clinical Information

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Dr Ewan Hutchison UK Civil Aviation Authority. ICAO European Regional Civil Aviation Medicine Seminar/Workshop București November 2013

Early Cancer Care FAQ

Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction

COSD & Source of Referral

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

DataDerm Quality Measures

Protection. Cancer Cover. Helping to protect you financially

Cancer arises from the mutation of a normal gene. A factor which brings about a mutation is called a mutagen.

23/04/2015. Recent advances in Melanoma and Non Melanoma Skin Cancer

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

UK CAA Oncology Certification Charts

Role of Cancer Registries and Data Banking in Quality Control of Breast Cancer Care

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

INTRODUCTION TO CANCER STAGING

Section 1: Personal information

Breast Cancer. For breast cancer, the mortality risk varies with the stage of the cancer.

Precision diagnostics for personalized melanoma care

LUNG CANCER Includes Invasive and Primary Cancers Only; Does Not Include Carcinoma In Situ or Metastatic Cancer

Breast Cancer Services in Germany

BREAST CANCER PATHOLOGY

National Breast Cancer Audit next steps. Martin Lee

C1 Qu2 DP2 High levels of preventable chronic disease, injury and mental health problems - Cancer

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Causation Issues. Delay in Diagnosis of Cancer Cases. Prof Pat Price Imperial College London

Mammo-50 Eligibility Queries

Types of bladder cancer

Introduction 1. Executive Summary 5

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Diagnosis & Interventions

Transcription:

Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Cancer or Carcinoma in-situ. To enable us to assess the claim, please complete this report and return it directly to our company. For questions where date is applicable, please complete in the format of day/month/year. To be completed and signed by the Attending Physician I hereby certify that I personally examined the patient and my records and medical opinion are as follows: 1. Name of patient : NRIC no. : 2. Are you the patient s regular medical attendant? If yes, please provide details beginning with the first record in your clinic: Date(s) consulted Purpose & details of Consultation(s) Diagnosis Nature of treatment rendered, including type of tests and/or surgeries done If no, do you know the name and address of the patient s regular medical attendant(s)? Yes No If yes, please provide details: Name of medical attendant Address 3. Details of the consultation 3.1 Date you were first consulted for cancer or carcinoma in-situ: Page 1 of 7

3.2 State the symptoms presented, the medical history as presented by the patient and date when the symptoms first appeared. Symptoms Presented at first consultation Date symptoms first started 3.3 Where is the source of this information about the patient s condition? (Patient or referring doctor or others. If others, please specify) 3.4 In your opinion, how long do you think the symptoms first appeared prior to consulting you? 3.5 If the patient was referred to you OR if the patient had seen other doctor(s) before consulting you for this medical condition or its symptoms, please provide details: Name of doctor(s) or hospital(s) Address of doctor(s) or hospital(s) Date consulted or date referred to you (Please continue with your documentation on a blank page if there are more than 3 records and attached it with this report) 4. Details of the illness 4.1 Details of diagnosis: Doctor s diagnosis Diagnosis date Underlying cause (if any) 4.2 Date of when patient was first informed of the diagnosis: Page 2 of 7

4.3 Name of doctor or hospital who first made the diagnosis: 4.4 What was the site or organ involved and the precise histology of the tumour? _ 4.5 What is the staging of the tumour? Please provide full details using appropriate staging classification (e.g. TMN classification etc). 4.6 What is the size of the tumour? 4.7 Was the disease completely localised? 4.8 Was there invasion to the surrounding or adjacent tissues? If yes, please state the sites or tissues which showed evidence of invasion. 4.9 Were regional lymph nodes involved? 4.10 Were there distant metastases? 4.11 If the diagnosis is leukaemia, please provide details of the actual type. _ 4.12 If the diagnosis is skin cancer, is it a hyperkeratosis, basal cell and squamous skin cancer? 4.13 If the diagnosis is malignant melanomas, is the melanomas of less than 1.5mm Breslow thickness, or less than Clark Level 3? If no, please state full details of size, thickness (Breslow classification) and/or depth of invasion (Clark level). _ Page 3 of 7

4.14 Was the diagnosis of cancer or carcinoma in-situ supported by histological, radiological or laboratory evidence and confirmed by an oncologist or pathologist? (a) If yes, please state mode of investigation done to establish the above diagnosis and attach copies of histological, radiological, laboratory results and operation reports. (b) If no, why and on what basis did you derive at such diagnosis? 4.14 Is the patient s condition or surgery performed in any way related or due (a) to: AIDS or HIV related illness? (b) Use of drug not prescribed by a registered medical practitioner or drug abuse? If yes, please provide details and enclose a copy of the test result: Diagnosis date Name and address of doctor who first diagnosed the patient with HIV, AIDS or drug abuse 5. Details of treatment and surgery 5.1 State the full details of all treatment provided (example medication, chemotherapy, radiotherapy). Nature of treatment Date(s) of treatment 5.2 Was there any surgery performed or going to be performed? If yes, please provide details and enclose a copy of the operation report: Nature of surgery performed or going to be performed Date(s) of surgery Page 4 of 7

5.3 (a) If the patient was diagnosed with breast or prostate cancer, was mastectomy or prostatectomy carried out? (b) Was there any other mode of treatment other than mastectomy or prostatectomy which could be undertaken to treat the patient s condition? If yes, please specify what was the alternate treatment and why was this treatment not undertaken. 5.4 Patient s response to the treatment: 5.5 Was the patient referred to other doctor(s) for follow up or further management? If yes, please state name and address of doctor(s) or hospital(s) and the reason(s) for referral. 5.6 Is the patient still on follow up treatment with you? If yes, please state the follow up treatment plan. 6. Regarding the patient s medical history 6.1 Has this patient previously suffered from the same condition or any related illnesses? If yes, please provide details: Date of when condition was first diagnosed Resulting diagnosis Name and address of doctor who attended to patient (if not attended to by you). Page 5 of 7

6.2 Is the patient suffering from or suffered from any other medical conditions? If yes, please provide details: Name of doctor(s) or hospital(s) & Address Diagnosis Diagnosis date Nature of treatment rendered, including type of tests and/or surgeries done (Please continue with your documentation on a blank page if there are more than 3 records and attached it with this report) 6.3 Is there anything in the patient s personal medical history which would have increased the risk of Cancer? If yes, please provide full details, including the date of diagnosis, name and address of attending doctor and source of information. 6.4 Is there anything in the patient s family history which would have increased the risk of Cancer? If yes, please provide full details, including relationship, nature of illness, date of diagnosis and source of information. 6.5 Please provide details of the patient s habits in relation to cigarette smoking, including the duration of the smoking habit, number of cigarettes smoked per day and source of information. _ 6.6 Please provide details of the patient s habits in relation to alcohol consumption, including the amount of alcohol consumption per day and source of information. 7. Please provide us with any other additional information that will enable us in assessing this claim. Page 6 of 7

Date Name and signature of doctor Address and official stamp Qualifications Page 7 of 7